To include your compound in the COVID-19 Resource Center, submit it here.

Alkem Laboratories, Karo Bio deal

Alkem received exclusive rights to commercialize Karo Bio's metabolic candidate eprotirome in

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE